<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Adiponectin is a protein secreted by adipose cells that improves insulin sensitivity and possesses antiatherogenic properties </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the relationship between adiponectin levels and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> subtype </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using clinical, imaging, and laboratory data, 231 consecutive patients admitted to a university medical center over a 2-year period with <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> were categorized into four subtypes: intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (n = 67), extracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (n = 61), small <z:mp ids='MP_0006134'>arterial occlusion</z:mp> (n = 63), and cardioembolic (n = 40) </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical features, risk factors including the presence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and levels of s-adiponectin were compared between groups </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Patients with more severe <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> were more likely to have lower s-adiponectin levels (p = 0.002) </plain></SENT>
<SENT sid="5" pm="."><plain>S-adiponectin levels differed by <z:hpo ids='HP_0001297'>stroke</z:hpo> subtype: highest in the cardioembolic group and lowest in the intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> group (8.42 +/- 5.07 vs 5.60 +/- 2.79 microg/mL, p = 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Extracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (6.45 +/- 4.10 microg/mL) and small <z:mp ids='MP_0006134'>arterial occlusion</z:mp> (6.07 +/- 3.44 microg/mL) groups were intermediate </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with advanced intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (&gt; or =1 additional lesion outside the symptomatic arterial territory) had lower s-adiponectin levels than those with isolated intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (4.95 +/- 2.63 vs 6.13 +/- 2.84 microg/mL, p = 0.003) </plain></SENT>
<SENT sid="8" pm="."><plain>In multiple regression analysis, s-adiponectin levels, but not <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, were independently associated with intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Symptomatic intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is associated with lower s-adiponectin levels vs other <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> subtypes </plain></SENT>
</text></document>